Skip to main content
Clinical Trials/NCT05128227
NCT05128227CompletedNot Applicable

PHARM-S.A.V.E.S: Suicide Prevention Gatekeeper Training for Pharmacy Staff

University of North Carolina, Chapel Hill2 sites in 1 country119 target enrollmentStarted: April 15, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
119
Locations
2
Primary Endpoint
Change in proportion of participants who ask about suicide.

Study Overview

Brief Summary

This is a pilot Randomized Controlled Trial (RCT) in which 150 pharmacy staff members will be randomized to an experimental or control group and data on suicide prevention communication and secondary outcomes will be collected over the course of the RCT.

Detailed Description

This is a prospective pilot RCT that will evaluate the impact of suicide prevention gatekeeper training (Pharm-SAVES) on 150 pharmacy staff member communication behaviors (primary outcome). Data will be collected at baseline, immediately after training is completed, and at 1-month follow up. Data sources include simulated patient observations (to rate quality of communication) and survey data (for self-reports of knowledge, self-efficacy, and referral behaviors).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Staff must:
  • be at least 18 years of age;
  • read and speak English; and
  • be currently employed as a pharmacist or pharmacy technician at a community pharmacy

Exclusion Criteria

  • Individuals will be excluded if they hold floater status (non-staff pharmacists or technicians).

Outcomes

Primary Outcomes

Change in proportion of participants who ask about suicide.

Time Frame: Baseline and immediately post-intervention

An online survey will include a written case that asks participants what they would say to a patient who has expressed verbal suicide warning sign(s). Blinded coders will review the open-ended response to determine whether the participant asks about suicide. The responses will be coded as no=0 and yes=1.

Secondary Outcomes

  • Change in proportion of participants who report they would call the National Suicide Prevention Lifeline.(Baseline and immediately post-intervention)
  • Change in suicide prevention knowledge score from baseline to immediate post-intervention.(Baseline and immediately post-intervention)
  • Change in mean suicide prevention self-efficacy score from baseline to 1-month follow-up(Baseline and 1-month follow-up)
  • Change in mean suicide prevention preparedness score from baseline to 1-month follow-up.(Baseline and 1-month follow-up)
  • Proportion of participants who ask about suicide (optional)(1-month follow-up)
  • Change in mean suicide prevention self-efficacy score from baseline to immediate post-intervention.(Baseline and immediately post-intervention)
  • Change in mean suicide prevention preparedness score from baseline to immediate post-intervention.(Baseline and immediately post-intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials